These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16936109

  • 1. Interferon-alpha: a key factor in autoimmune disease?
    Plskova J, Greiner K, Muckersie E, Duncan L, Forrester JV.
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
    [Abstract] [Full Text] [Related]

  • 2. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.
    Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis.
    Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV, Dick AD.
    Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282
    [Abstract] [Full Text] [Related]

  • 4. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
    Greiner K, Murphy CC, Willermain F, Duncan L, Plskova J, Hale G, Isaacs JD, Forrester JV, Dick AD.
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK, Seo JM, Yu J, Oh FS, Chung H, Yu HG.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of human immunodeficiency virus gp120 and Tat on CpG-A-induced inflammatory cytokines in plasmacytoid dendritic cells.
    Fang M, Xu N, Shao X, Yang J, Wu N, Yao H.
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):797-804. PubMed ID: 22814248
    [Abstract] [Full Text] [Related]

  • 7. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.
    Murphy CC, Duncan L, Forrester JV, Dick AD.
    Br J Ophthalmol; 2004 Mar; 88(3):412-6. PubMed ID: 14977779
    [Abstract] [Full Text] [Related]

  • 8. Chemokine receptors and early activation markers in acute anterior uveitis.
    Klitgaard TL, Øgard C, Krogh E.
    Acta Ophthalmol Scand; 2004 Apr; 82(2):179-83. PubMed ID: 15043537
    [Abstract] [Full Text] [Related]

  • 9. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
    Yilmaz S, Cinar M, Pekel A, Simsek I, Musabak U, Erdem H, Pay S.
    Clin Exp Rheumatol; 2013 Apr; 31(3 Suppl 77):84-7. PubMed ID: 24064021
    [Abstract] [Full Text] [Related]

  • 10. Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
    Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.
    Hum Vaccin Immunother; 2015 Apr; 11(9):2253-65. PubMed ID: 26091502
    [Abstract] [Full Text] [Related]

  • 11. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
    Amberger M, Groll S, Günaydin I, Deuter C, Vonthein R, Kötter I.
    Clin Exp Rheumatol; 2007 Apr; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis.
    Plskova J, Greiner K, Forrester JV.
    Am J Ophthalmol; 2007 Jul; 144(1):55-61. PubMed ID: 17601428
    [Abstract] [Full Text] [Related]

  • 13. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH, Hsieh CC, Kuo HF, Huang MY, Yang SN, Chen LC, Huang SK, Hung CH.
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation.
    Barblu L, Machmach K, Gras C, Delfraissy JF, Boufassa F, Leal M, Ruiz-Mateos E, Lambotte O, Herbeuval JP, ANRS EP36 HIV Controllers Study Group.
    J Infect Dis; 2012 Sep 01; 206(5):790-801. PubMed ID: 22693234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.
    Novak N, Allam JP, Hagemann T, Jenneck C, Laffer S, Valenta R, Kochan J, Bieber T.
    J Allergy Clin Immunol; 2004 Aug 01; 114(2):364-70. PubMed ID: 15316517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.